Word

UNICLONE

Status

Dead

Status Code

710

Status Date

Friday, May 9, 2014

Serial Number

78131079

Registration Number

2771609

Registration Date

Tuesday, October 7, 2003

Mark Type

1000

Filing Date

Friday, May 24, 2002

Published for Opposition

Tuesday, July 15, 2003

Cancellation Date

Friday, May 9, 2014

Trademark Owner History

Protagen AG - Original Registrant

Classifications

5 Pharmaceutical and veterinarian preparations containing therapeutic proteins, therapeutic nucleicacids, gene and/or cells for health and medical care, namely, for the treatment of allergies, arthritis, cancer, diabetes, diseases of the central nervous system, inflammatory diseases, metabolic disorders, viral diseases; pharmaceutical preparations for use in cardiology and oncology; medical and pharmaceutical products, namely human vaccines, anti-infectives, diagnostic proteins, therapeutic proteins, therapeutic nucleicacids, gene and/or cells; medical, biotechnological and gene-technological products and preparations obtainable by protein-expression-banks and nucleicacid-banks together with expression-vectors, proteomics, proteome-analysis, biochips, comprising proteins and nucleicacids, protein-biochips, arrays for use in or at human beings or animals, namely, proteins; diagnostics and detergents for medical and veterinarian use, namely diagnostic preparations and reagents for clinical or medical laboratory use

9 Scientific devices and instruments for the protein-expression in a protein-expression bank, namely, protein-biochips, comprising clones for identification and validation of proteins and encoding nucleicacids together with expression-vectors thereof

42 Services for chemical, pharmaceutical, biotechnological, diagnostical, analytical, gene-technological, medical laboratories or industrial facilities or research- and development facilities, namely consulting and analysis in the field of chemistry, pharmacy, biotechnology, diagnostic, analytical, gene-technology, bio-informatics, target validation and drug development, by means of nucleicacid- or protein-biochips, protein-expression-banks, nucleicacid-banks, polypeptide or nucleicacid-libraries and arrays, automation, application and use of protein-biochips; consulting and analysis in the field of automation, application and use of proteomics, proteome studies, proteome designs, peptide and protein analytic and identification, purification and characterization, 1 D and 2D gele electrophorese, mass spectrometry, robotics for proteomics and protein-expression-banks

Trademark Events

May 9, 2014

Cancelled Sec. 8 (10-Yr)/Expired Section 9

Oct 22, 2009

Registered - Sec. 8 (6-Yr) Accepted & Sec. 15 Ack.

Oct 22, 2009

Case Assigned To Post Registration Paralegal

Oct 7, 2009

Teas Section 8 & 15 Received

Oct 7, 2009

Applicant/Correspondence Changes (Non-Responsive) Entered

Oct 7, 2009

Teas Change Of Owner Address Received

Jul 18, 2008

Case File In Ticrs

Oct 7, 2003

Registered-Principal Register

Jul 15, 2003

Published For Opposition

Jun 25, 2003

Notice Of Publication

Apr 24, 2003

Approved For Pub - Principal Register

Mar 21, 2003

Correspondence Received In Law Office

Mar 21, 2003

Paper Received

Jan 8, 2003

Non-Final Action E-Mailed

Oct 11, 2002

Assigned To Examiner

Sep 19, 2002

Assigned To Examiner